TriSalus Life Sciences Warrant
TLSIW
4 hedge funds and large institutions have $337K invested in TriSalus Life Sciences Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
2.95% less ownership
Funds ownership: 2.95% → 0% (-3%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
73% less capital invested
Capital invested by funds: $1.25M → $337K (-$912K)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$188K |
Top Sellers
| 1 |
ACM
Alpha Capital Management
Austin,
Texas
|
-$20.4K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$7.66K |
TLSIW Hedge Fund Activity: Q3 2025 in Review
4 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2025, worth a combined $337K — down 73% from $1.25M a quarter earlier.
Fund positioning in TLSIW was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $188K. The largest seller was Alpha Capital Management, cutting an estimated $20.4K.
- 4 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2025, down from 5 in Q2 2025.
- Funds reported $337K of TriSalus Life Sciences Warrant stock for Q3 2025, down 73% quarter-over-quarter.
- 0 funds opened new TriSalus Life Sciences Warrant positions in Q3 2025 and 0 closed out.
- The largest TriSalus Life Sciences Warrant buyer in Q3 2025 was Citadel Advisors, an estimated $188K added.
- The largest TriSalus Life Sciences Warrant seller in Q3 2025 was Alpha Capital Management, an estimated $20.4K sold.
Based on aggregated 13F filings for Q3 2025.